Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tideglusib may help bone regeneration without being toxic at low doses.

New psoriasis treatments are effective but come with side effects and risks.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Oral baricitinib is effective and safe for treating alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Upadacitinib effectively treats pyoderma gangrenosum.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Tofacitinib may help regrow hair in alopecia areata patients.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Oral alitretinoin is effective for certain types of chronic hand eczema, with mild side effects.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

The new delivery system improves Alzheimer's symptoms by releasing Huperzine A slowly and effectively.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.